The NDDA represents one of the nation’s greatest geographic concentrations of experienced pharmaceutical development, clinical research and bioscience companies– right in the heart of the country. The companies in the NDDA have helped develop more than 50 of the world’s top drugs.
The NDDA builds on the legacy of Ewing Kauffman and Marion Laboratories, as well as a well-organized industry, the aggressive Kansas Bioscience Authority, university expertise and a deep talent pool to fuel growth.
The NDDA will streamline your development and approval process, offering comprehensive, best in class, cost efficient services and strategies to accelerate your drug development programs.
The typical process for development, testing and regulatory approval can span a decade and cost more than $1 billion. Every day subtracted from the process can be worth literally millions of dollars.
The collaboration throughout the process of geographically concentrated companies with world-class expertise provides you with a clear advantage from the outset. Efficiencies are gained throughout the life of the process because of our hghly integrated network of regional service providers.
The end result? You leverage your investment; invest less in terms of time and money. Your product reaches proof of concept quicker and is commercialized faster. Patients benefit sooner.
Here, you’ll find a deep pool of resources throughout the drug development process. From drug discovery, through preclinical, nonclinical and contract research to scientific and regulatory consulting to safety, efficacy and esoteric testing, NDDA members offer comprehensive services and world-class science through the entire drug development process.
Our members’ strict application to cGMP and ISO quality systems keep clients coming back. Add a highly compliant population, low cost of living and a centralized location with nonstop access to either coast.
Cost structure + efficiency = unparalleled value.
In addition to the significant drug development expertise, time savings, and increased profits you will enjoy with the NDDA, we offer a wide range of financial assistance in Kansas to ensure your business success. Along with tax incentives, job training grants, and other business assistance available in the state, the innovative Kansas Bioscience Authority is directly investing $581 million in R&D, commercialization, and industrial growth, with a strong emphasis on accelerating the work of researchers and companies in drug discovery and delivery.
Beckloff Associates is a full-service pharmaceutical research and development consulting firm
“After working for four years at the Food & Drug Administration, and now four years with the Senate, I can honestly say that I have never seen anything like the collaborative effort you have in Kansas…from drug discovery and delivery activities through drug development and the high concentration of clinical trials in this region.”
--Stacy McHatton McBride
Committee on Appropriations
United States Senate